Skip to main content

Medtronic plc Specialty Therapies revenue

  • MDT · NYSE
  • Medical devices
  • Health Care Equipment
  • S&P 500
$102.86+1.85%Close 13 Nov 2026 · Market value $132.0B · Next results 24 Nov 2026

Specialty Therapies revenue at Medtronic plc came to $774.0M for the quarter to 31 Jul 2026, up 10.3% from a year earlier.

As Medtronic plc reported it in its earnings release and quarterly or annual report, compiled and checked by AapWire. Latest figure filed 3 Sep 2026.

By quarter

$705.0MOct 2023$726.0MJan 2024$779.0MApr 2024$713.0MJul 2024$737.0MOct 2024$732.0MJan 2025$759.0MApr 2025$702.0MJul 2025$744.0MOct 2025$746.0MJan 2026$806.0MApr 2026$774.0MJul 2026
Medtronic plc Specialty Therapies revenue, every reported period
Period endingSpecialty Therapies revenueChange on a yearFiled
31 Jul 2026$774.0Mup 10.3%3 Sep 2026
24 Apr 2026$806.0Mup 6.2%18 Jun 2026
23 Jan 2026$746.0Mup 1.9%24 Feb 2026
24 Oct 2025$744.0Mup 0.9%25 Nov 2025
25 Jul 2025$702.0Mdown 1.5%26 Aug 2025
25 Apr 2025$759.0Mdown 2.6%20 Jun 2025
24 Jan 2025$732.0Mup 0.8%25 Feb 2025
25 Oct 2024$737.0Mup 4.5%26 Nov 2024
26 Jul 2024$713.0Mup 2.6%27 Aug 2024
26 Apr 2024$779.0Mup 2.1%20 Jun 2024
26 Jan 2024$726.0Mup 3.9%27 Feb 2024
27 Oct 2023$705.0Mup 2.8%30 Nov 2023
28 Jul 2023$695.0Mup 4.2%31 Aug 2023
28 Apr 2023$763.0Mup 11.5%22 Jun 2023
27 Jan 2023$699.0Mup 10.4%1 Mar 2023
28 Oct 2022$686.0Mup 8.2%1 Dec 2022
29 Jul 2022$667.0Mup 4.1%1 Sep 2022
29 Apr 2022$684.0Mup 4.6%23 Jun 2022
28 Jan 2022$633.0Mup 2.4%3 Mar 2022
29 Oct 2021$634.0Mup 9.1%2 Dec 2021
30 Jul 2021$641.0Mup 41.5%2 Sep 2021
30 Apr 2021$654.0M—25 Jun 2021
29 Jan 2021$618.0M—5 Mar 2021
30 Oct 2020$581.0M—3 Dec 2020
31 Jul 2020$453.0M—3 Sep 2020

Definition

Revenue from this part of the business, as the company names and reports it in its results. Each figure is read from the table or sentence the company printed and kept with its scale and decimals; see data and methodology.

Other operating KPIs of Medtronic plc: Electrophysiology Therapies revenue · Surgical & Endoscopy revenue · Cranial & Spinal Technologies revenue · Structural Heart & Aortic revenue · Coronary & Peripheral Vascular revenue · Acute Care & Monitoring revenue · Neuromodulation revenue · Reportable segment net sales · Cardiovascular revenue · Neuroscience revenue · Medical Surgical revenue · Diabetes revenue · United States revenue · International revenue · Rest of world revenue · Ireland revenue · financial statements

Every KPI and segment of MDT, in the terminal.

Ten years of operating figures, segments, guidance against results, charts and alerts on each new release.